调查每个MELD版本在预测肝移植结果方面的有用性
Erin Neely Burns1, Oliver Roche Perrine1, Victoria Jackson Comfort1
1College of Osteopathic Medicine, William Carey University, Hattiesburg, MS, United States.
American journal of surgery
|February 20, 2026
概括
末期肝病模型 (MELD) 3.0显示了与移植后结果的多种关联,包括较高的移植失败风险和较低的复发性疾病风险. 监测这些变化对于肝移植分配公平性至关重要.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 移植手术 移植手术
- 医疗信息学 医疗信息学
背景情况:
- 末期肝病模型 (MELD) 自2002年以来一直指导肝移植候选人优先选择.
- 修订包括MELD 2.0 (2016) 和MELD 3.0 (2022),旨在改善分配权益.
- 这些MELD版本对移植后结果的预测准确性需要研究.
研究的目的:
- 评估MELD队列 (1.0,2.0和3.0) 与10个关键移植后结果之间的关联.
- 将MELD 2.0和MELD 3.0的预测性能与参考MELD 1.0.0进行比较.
- 了解MELD更新如何影响移植结果.
主要方法:
- 使用器官采购移植网络 (OPTN) 数据库进行分析.
- 采用二进制物流回归来评估MELD队列关联与移植后结果.
- 根据MELD得分进行调整,使用MELD 1.0作为参考队列.
主要成果:
- MELD 3.0显示了与感染造成的移植失败 (OR=1.30),肝动脉血栓 (OR=2.51) 和初级非功能 (OR=3.93) 的显著关联.
- MELD 3.0与复发性疾病 (OR=0.12) 和肝炎 (OR=0.03) 的风险降低有关.
- 与MELD 1.0.0相比,MELD 2.0显示急性排斥 (OR=1.58) 和慢性排斥 (OR=1.28) 的风险增加.
结论:
- 在MELD 3.0队列中,与移植后风险的增加和减少都有显著的关联.
- 这些发现凸显了监测分配政策对人口水平结果的影响的必要性.
- 需要进一步的研究来完善MELD对肝移植的预测能力.
相关概念视频
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
225
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
225
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
272
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
272